Riskpilot← Back to searchSign inGet full accessDS Med AB
ABActiveOrg 5593459463Vätterslundsgatan 5 AGeneral medical practice activities · NACE 8621Est. 20211 employees
Revenue 2025
SEK 576K
+68% vs 2024
EBITDA margin
-5.3%
-130% vs 2024
Equity ratio
47.7%
Financial strength
Net profit 2025
SEK -36K
-146% vs 2024
| Revenue | SEK 576K | +68% |
| EBITDA | SEK -31K | -130% |
| Net profit | SEK -36K | -146% |
| Total assets | SEK 188K | +10% |
| Equity | SEK 90K | -29% |
| Employees | 1 | — |
Legal name
DS Med AB
Org number
5593459463
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
12 november 2021
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget kommer att erbjuda allmänmedicinsk konsultverksamhet. Uppdraget omfattar bemanning på vårdcentral, hälsocentral. Vi kommer även att erbjuda bemanning för läkare på digitala vårdtjänster. Uppdraget omfattar enbart läkare med svensk läkarlegitimation. Över tid är målet att erbjuda även konsultverksamhet för försäkring- samt företagshälsovård.
Address
Vätterslundsgatan 5 A
Email
ds.medab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 78 | 342 | 576 |
| Staff expenses | — | — | −164 | −334 |
| EBITDA | −7 | 38 | 102 | −31 |
| Depreciation & amort. | — | — | — | — |
| EBIT | −7 | 38 | 102 | −31 |
| Net financials | — | −2 | −1 | −2 |
| Profit before tax | −7 | 35 | 100 | −33 |
| Tax | — | −6 | −22 | −3 |
| Net profit | −7 | 29 | 78 | −36 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 18 | 63 | 170 | 188 |
| Equity | 18 | 47 | 125 | 90 |
| Long-term debt | — | — | — | — |
| Short-term debt | — | 16 | 45 | 98 |
| Total debt | — | 16 | 45 | 98 |
EBITDA margin
-5.3%
This company
15.8%
Market median
-134% vs market
20222025
Equity ratio
47.7%
This company
38.2%
Market median
+25% vs market
20222025
Return on equity
-40.0%
This company
18.4%
Market median
-317% vs market
20222025
Net profit margin
-6.2%
This company
8.1%
Market median
-177% vs market
20222025
Asset turnover
3.07×
This company
1.12×
Market median
+174% vs market
20222025
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-12 – 2022-10-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DS Med AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Adnela Duhera | Deputy Board Member | 0 companies |
| Sabahudin Duhera | Board of Directors | 0 companies |